In-vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa
- PMID: 10552987
- DOI: 10.1093/jac/44.5.689
In-vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa
Abstract
We evaluated the in-vitro effects of various combinations of five types of widely used antipseudomonal antibiotics (piperacillin, meropenem, ceftazidime, aztreonam and amikacin) against six Pseudomonas aeruginosa strains that were resistant to each of these antibiotics. Among two-drug combinations, the combinations of two beta-lactam antibiotics inhibited growth of one to three P. aeruginosa strains, while those of one beta-lactam antibiotic and amikacin inhibited growth of two to four strains. Among three-drug combinations, the combinations of three beta-lactam antibiotics inhibited growth of four to five strains, and those of two beta-lactam antibiotics and amikacin inhibited growth of five strains. These results suggest the potential usefulness of a combination of two beta-lactam antibiotics and amikacin or that of three beta-lactam antibiotics in treating multi-drug resistant P. aeruginosa infections.
Similar articles
-
Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.Microbiol Spectr. 2021 Sep 3;9(1):e0058521. doi: 10.1128/Spectrum.00585-21. Epub 2021 Jul 28. Microbiol Spectr. 2021. PMID: 34319141 Free PMC article.
-
In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa.J Antimicrob Chemother. 2003 Dec;52(6):911-4. doi: 10.1093/jac/dkg478. Epub 2003 Oct 29. J Antimicrob Chemother. 2003. PMID: 14585851
-
Activity of antibiotics against resistant Pseudomonas aeruginosa.J Antimicrob Chemother. 1992 May;29(5):539-46. doi: 10.1093/jac/29.5.539. J Antimicrob Chemother. 1992. PMID: 1365010
-
Pseudomonas aeruginosa: resistance and therapy.Semin Respir Infect. 2002 Sep;17(3):231-9. doi: 10.1053/srin.2002.34689. Semin Respir Infect. 2002. PMID: 12226802 Review.
-
An evaluation of antipseudomonal antimicrobic agents.Antibiot Chemother (1971). 1985;36:111-33. doi: 10.1159/000410477. Antibiot Chemother (1971). 1985. PMID: 3923909 Review.
Cited by
-
In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains.Yonsei Med J. 2010 Jan;51(1):111-6. doi: 10.3349/ymj.2010.51.1.111. Epub 2009 Dec 29. Yonsei Med J. 2010. PMID: 20046523 Free PMC article.
-
Evaluation of Aminoglycoside and Carbapenem Resistance in a Collection of Drug-Resistant Pseudomonas aeruginosa Clinical Isolates.Microb Drug Resist. 2018 Sep;24(7):1020-1030. doi: 10.1089/mdr.2017.0101. Epub 2017 Dec 20. Microb Drug Resist. 2018. PMID: 29261405 Free PMC article.
-
Ceftolozane/tazobactam for febrile UTI due to multidrug-resistant Pseudomonas aeruginosa in a patient with neurogenic bladder.Spinal Cord Ser Cases. 2017 May 11;3:17019. doi: 10.1038/scsandc.2017.19. eCollection 2017. Spinal Cord Ser Cases. 2017. PMID: 28503325 Free PMC article.
-
In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-beta-lactamase-producing Pseudomonas aeruginosa.BMC Infect Dis. 2009 Aug 10;9:123. doi: 10.1186/1471-2334-9-123. BMC Infect Dis. 2009. PMID: 19664245 Free PMC article.
-
Successful Treatment of Multi-Drug Resistant Pseudomonas aeruginosa Bacteremia with the Recommended Renally Adjusted Ceftolozane/Tazobactam Regimen.Infect Dis Ther. 2016 Mar;5(1):73-9. doi: 10.1007/s40121-016-0104-3. Epub 2016 Mar 2. Infect Dis Ther. 2016. PMID: 26935574 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical